- Home
- / ACell
ACell
Revenue
$100.8 M
FY, 2019
ACell Summary
Company Summary
- Overview
- ACell is a regenerative medicine company focused on the development, manufacturing, and commercialization of medical devices for wound management and surgical soft tissue repair. It offers MatriStem UBM (Urinary Bladder Matrix) technology that facilitates the body's ability to remodel functional tissue.
- Type
- Public
- Status
- Active
- Founded
- 2002
- HQ
- Columbia, MD, US | view all locations
- Website
- https://www.acell.com/
- Cybersecurity rating
Table of Contents
Key People
Chris Branch, Chief Operating Officer
Matthew Kunst, Treasurer and Chief Financial Officer
Nino Pionati, Chief Commercial Officer
Operating MetricsView all
Customers
1.9K
FY, 2019
Distributors
7
FY, 2019
Countries
11
FY, 2019
LocationsView all
2 locations detected
Columbia, MD HQ
United States
6640 Eli Whitney Dr # 200
Lafayette, IN
United States
3589 Sagamore Pkwy N
ACell Financials
Summary Financials
- Revenue (FY, 2019)
- $100.8M
- Gross profit (FY, 2019)
- $81.7M
- Net income (FY, 2019)
- $1.4M
- Cash (FY, 2019)
- $7.0M
- EBIT (FY, 2019)
- $1.4M